2016, DeriveApprodi, ISBN 9788865481677, Volume 126, 133 pages
Book
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 117, Issue 11, pp. 1714 - 1723
The purpose of the study was to evaluate the optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention, especially in the...
Cardiovascular | TRIAL | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | CLOPIDOGREL | EVENTS | EFFICACY | IMPLANTATION | THROMBOSIS | DISCONTINUATION | Drug-Eluting Stents | Coronary Artery Disease - therapy | Global Health | Hemorrhage - epidemiology | Humans | Platelet Aggregation Inhibitors - administration & dosage | Hemorrhage - chemically induced | Drug Therapy, Combination | Prosthesis Design | Percutaneous Coronary Intervention | Incidence | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Analysis | Stent (Surgery) | Medicine, Experimental | Medical research | Hypothesis testing | Heart attacks | Mortality | Gender | Regression analysis | Meta-analysis | Studies | Confidence intervals | Hypotheses | Collaboration | Diabetes | Prodigies | Acute coronary syndromes | Stents | Age
Cardiovascular | TRIAL | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | CLOPIDOGREL | EVENTS | EFFICACY | IMPLANTATION | THROMBOSIS | DISCONTINUATION | Drug-Eluting Stents | Coronary Artery Disease - therapy | Global Health | Hemorrhage - epidemiology | Humans | Platelet Aggregation Inhibitors - administration & dosage | Hemorrhage - chemically induced | Drug Therapy, Combination | Prosthesis Design | Percutaneous Coronary Intervention | Incidence | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Analysis | Stent (Surgery) | Medicine, Experimental | Medical research | Hypothesis testing | Heart attacks | Mortality | Gender | Regression analysis | Meta-analysis | Studies | Confidence intervals | Hypotheses | Collaboration | Diabetes | Prodigies | Acute coronary syndromes | Stents | Age
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 169, Issue 5, pp. 663 - 673
Introduction Accuracy of intracoronary imaging to discriminate functionally significant coronary stenosis according to vessel diameter remains to be defined....
Cardiovascular | FRACTIONAL FLOW RESERVE | QUANTITATIVE ANGIOGRAPHY | LUMEN AREA PARAMETERS | CARDIAC & CARDIOVASCULAR SYSTEMS | LEFT MAIN | REFERENCE-STANDARD | FOLLOW-UP | COMPUTED-TOMOGRAPHY | ARTERY-DISEASE | CLINICAL-OUTCOMES | DIAGNOSTIC-ACCURACY | Coronary Stenosis - diagnostic imaging | Coronary Vessels - diagnostic imaging | Coronary Vessels - pathology | Area Under Curve | Tomography, Optical Coherence | Humans | Middle Aged | Ultrasonography, Interventional | Male | Sensitivity and Specificity | Adult | Female | ROC Curve | Coronary Stenosis - diagnosis | Stenosis | Studies | Ultrasonic imaging | Accuracy | Medical imaging | Heart attacks | Coronary vessels | Cardiovascular disease | Diabetes | Meta-analysis
Cardiovascular | FRACTIONAL FLOW RESERVE | QUANTITATIVE ANGIOGRAPHY | LUMEN AREA PARAMETERS | CARDIAC & CARDIOVASCULAR SYSTEMS | LEFT MAIN | REFERENCE-STANDARD | FOLLOW-UP | COMPUTED-TOMOGRAPHY | ARTERY-DISEASE | CLINICAL-OUTCOMES | DIAGNOSTIC-ACCURACY | Coronary Stenosis - diagnostic imaging | Coronary Vessels - diagnostic imaging | Coronary Vessels - pathology | Area Under Curve | Tomography, Optical Coherence | Humans | Middle Aged | Ultrasonography, Interventional | Male | Sensitivity and Specificity | Adult | Female | ROC Curve | Coronary Stenosis - diagnosis | Stenosis | Studies | Ultrasonic imaging | Accuracy | Medical imaging | Heart attacks | Coronary vessels | Cardiovascular disease | Diabetes | Meta-analysis
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2017, Volume 119, Issue 7, pp. 978 - 982
Incidence, predictors, and impact on prognosis of target lesion revascularization (TLR) for patients treated with second-generation drug-eluting stents (DESs)...
Cardiovascular | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | DISTAL | IMPLANTATION | CARDIAC-SURGERY | 3-VESSEL | OUTCOMES | CORONARY-ARTERY-DISEASE | ANGIOGRAPHIC FOLLOW-UP | REGISTRY | Drug-Eluting Stents | Prognosis | Tomography, Optical Coherence | Humans | Ultrasonography, Interventional | Male | Treatment Outcome | Coronary Artery Disease - mortality | Cause of Death | Coronary Restenosis - therapy | Incidence | Coronary Angiography | Retreatment | Coronary Restenosis - epidemiology | Coronary Artery Disease - therapy | Percutaneous Coronary Intervention - methods | Coronary Restenosis - mortality | Female | Aged | Retrospective Studies | Transluminal angioplasty | Shock | Medical research | Care and treatment | Analysis | Medicine, Experimental | Diabetes | Coronary heart disease | Stent (Surgery) | Variables | Heart attacks | Medical prognosis | Cardiovascular disease | Angina pectoris | Multivariate analysis | Stents | Thrombosis | Insulin
Cardiovascular | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | DISTAL | IMPLANTATION | CARDIAC-SURGERY | 3-VESSEL | OUTCOMES | CORONARY-ARTERY-DISEASE | ANGIOGRAPHIC FOLLOW-UP | REGISTRY | Drug-Eluting Stents | Prognosis | Tomography, Optical Coherence | Humans | Ultrasonography, Interventional | Male | Treatment Outcome | Coronary Artery Disease - mortality | Cause of Death | Coronary Restenosis - therapy | Incidence | Coronary Angiography | Retreatment | Coronary Restenosis - epidemiology | Coronary Artery Disease - therapy | Percutaneous Coronary Intervention - methods | Coronary Restenosis - mortality | Female | Aged | Retrospective Studies | Transluminal angioplasty | Shock | Medical research | Care and treatment | Analysis | Medicine, Experimental | Diabetes | Coronary heart disease | Stent (Surgery) | Variables | Heart attacks | Medical prognosis | Cardiovascular disease | Angina pectoris | Multivariate analysis | Stents | Thrombosis | Insulin
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2017, Volume 120, Issue 1, pp. 33 - 39
Transradial access (TRA) is often avoided in favor of the transfemoral access (TFA) during percutaneous coronary interventions of the unprotected left main...
Cardiovascular | POSITION | TRIALS | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | FEASIBILITY | OUTCOMES | ARTERY-DISEASE | Catheterization, Peripheral - methods | Coronary Artery Disease - surgery | Drug-Eluting Stents | Follow-Up Studies | Humans | Male | Treatment Outcome | Prosthesis Design | Radial Artery | Percutaneous Coronary Intervention - methods | Coronary Vessels - surgery | Female | Femoral Artery | Registries | Aged | Retrospective Studies | Transluminal angioplasty | Care and treatment | Cardiology | Coronary heart disease | Stent (Surgery) | Intervention | Myocardial infarction | Surgical implants | Femur | Heart attacks | Cardiovascular disease | Drug delivery | Angina | Bleeding | Matching | Consortia | Elevation | Implants | Trends | Percutaneous treatment | Thromboembolism | Stents | Kidneys | Feasibility studies | Coronary artery | Angina pectoris | Patients | Thrombosis | Catheters | Coronary vessels | Infarction | Acute coronary syndromes
Cardiovascular | POSITION | TRIALS | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | FEASIBILITY | OUTCOMES | ARTERY-DISEASE | Catheterization, Peripheral - methods | Coronary Artery Disease - surgery | Drug-Eluting Stents | Follow-Up Studies | Humans | Male | Treatment Outcome | Prosthesis Design | Radial Artery | Percutaneous Coronary Intervention - methods | Coronary Vessels - surgery | Female | Femoral Artery | Registries | Aged | Retrospective Studies | Transluminal angioplasty | Care and treatment | Cardiology | Coronary heart disease | Stent (Surgery) | Intervention | Myocardial infarction | Surgical implants | Femur | Heart attacks | Cardiovascular disease | Drug delivery | Angina | Bleeding | Matching | Consortia | Elevation | Implants | Trends | Percutaneous treatment | Thromboembolism | Stents | Kidneys | Feasibility studies | Coronary artery | Angina pectoris | Patients | Thrombosis | Catheters | Coronary vessels | Infarction | Acute coronary syndromes
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 118, Issue 1, pp. 32 - 39
Percutaneous coronary intervention (PCI) of unprotected left main disease (ULM) with drug-eluting stents (DES) is hampered by lack of information on long-term...
Cardiovascular | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | INTERNAL MAMMARY ARTERY | FOLLOW-UP | BYPASS GRAFT-SURGERY | INTERVENTION | CORONARY-ARTERY-DISEASE | CLINICAL-OUTCOMES | Coronary Stenosis - complications | Drug-Eluting Stents | Coronary Stenosis - therapy | Humans | Middle Aged | Male | Treatment Outcome | Time Factors | Female | Aged | Coronary Stenosis - mortality | Retrospective Studies | Percutaneous Coronary Intervention | Transluminal angioplasty | Care and treatment | Analysis | Cardiac patients | Stenosis | Cardiology | Coronary heart disease | Stent (Surgery) | Studies | Hospitals | Heart attacks | Ischemia | Physicians | Population | Acute coronary syndromes | Multivariate analysis | Stents | Thrombosis
Cardiovascular | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | INTERNAL MAMMARY ARTERY | FOLLOW-UP | BYPASS GRAFT-SURGERY | INTERVENTION | CORONARY-ARTERY-DISEASE | CLINICAL-OUTCOMES | Coronary Stenosis - complications | Drug-Eluting Stents | Coronary Stenosis - therapy | Humans | Middle Aged | Male | Treatment Outcome | Time Factors | Female | Aged | Coronary Stenosis - mortality | Retrospective Studies | Percutaneous Coronary Intervention | Transluminal angioplasty | Care and treatment | Analysis | Cardiac patients | Stenosis | Cardiology | Coronary heart disease | Stent (Surgery) | Studies | Hospitals | Heart attacks | Ischemia | Physicians | Population | Acute coronary syndromes | Multivariate analysis | Stents | Thrombosis
Journal Article
Reti Medievali Rivista, 05/2017, Volume 18, Issue 1
L’articolo ricostruisce la storia intellettuale della poesia toscana del Duecento. In particolare, l’analisi individua nelle opere (poesie e lettere) e nella...
Guido Orlandi | Guittone d’Arezzo | Fiore | Roman de la Rose | Monte Andrea | Detto d’Amore
Guido Orlandi | Guittone d’Arezzo | Fiore | Roman de la Rose | Monte Andrea | Detto d’Amore
Journal Article
Reti Medievali Rivista, ISSN 1593-2214, 2017, Volume 18, Issue 1, pp. 219 - 270
Journal Article
Reti Medievali Rivista, 01/2017, Volume 18, Issue 1, p. 219
This paper traces the intellectual history of the Tuscan poetry of the thirteenth century. In particular, the analysis describes the cultural project derived...
Poetics | Middle Ages | Poetry
Poetics | Middle Ages | Poetry
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 08/2017, Volume 90, Issue 2, pp. E46 - E52
Aim. To determine the potential clinical impact of OCT (Optical Coherence Tomography) during primary percutaneous coronary intervention in patients presenting...
drug eluting stent | optical coherence tomography | acute coronary syndrome | CARDIAC & CARDIOVASCULAR SYSTEMS | LEFT MAIN | ATHEROSCLEROSIS | PLAQUE | INTRAVASCULAR ULTRASOUND GUIDANCE | TRIAL | THERAPY | INTERVENTION | ELEVATION MYOCARDIAL-INFARCTION | DRUG-ELUTING STENTS | ARTERY-DISEASE | Non-ST Elevated Myocardial Infarction - diagnostic imaging | Multivariate Analysis | Predictive Value of Tests | Recurrence | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | ST Elevation Myocardial Infarction - therapy | Percutaneous Coronary Intervention - instrumentation | Time Factors | Percutaneous Coronary Intervention - methods | Non-ST Elevated Myocardial Infarction - therapy | Female | Registries | Retrospective Studies | Stents | Tomography, Optical Coherence | Europe | Risk Factors | Acute Coronary Syndrome - diagnostic imaging | Angina, Unstable - mortality | Treatment Outcome | Coronary Angiography | Propensity Score | ST Elevation Myocardial Infarction - mortality | ST Elevation Myocardial Infarction - diagnostic imaging | Angina, Unstable - therapy | Acute Coronary Syndrome - therapy | Aged | Coronary Thrombosis - etiology | Non-ST Elevated Myocardial Infarction - mortality | Percutaneous Coronary Intervention - adverse effects | Angina, Unstable - diagnostic imaging | Transluminal angioplasty | Analysis | Cardiac patients | Tomography | Coronary heart disease | Thrombosis | Blood clot | Myocardial infarction | Intervention | Surgical implants | Statistical analysis | Medical imaging | Heart attacks | Angiography | Disorders | Patients | Incidence | Matching | Optical Coherence Tomography | Implants | Infarction | Acute coronary syndromes | Thromboembolism | Significance | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
drug eluting stent | optical coherence tomography | acute coronary syndrome | CARDIAC & CARDIOVASCULAR SYSTEMS | LEFT MAIN | ATHEROSCLEROSIS | PLAQUE | INTRAVASCULAR ULTRASOUND GUIDANCE | TRIAL | THERAPY | INTERVENTION | ELEVATION MYOCARDIAL-INFARCTION | DRUG-ELUTING STENTS | ARTERY-DISEASE | Non-ST Elevated Myocardial Infarction - diagnostic imaging | Multivariate Analysis | Predictive Value of Tests | Recurrence | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | ST Elevation Myocardial Infarction - therapy | Percutaneous Coronary Intervention - instrumentation | Time Factors | Percutaneous Coronary Intervention - methods | Non-ST Elevated Myocardial Infarction - therapy | Female | Registries | Retrospective Studies | Stents | Tomography, Optical Coherence | Europe | Risk Factors | Acute Coronary Syndrome - diagnostic imaging | Angina, Unstable - mortality | Treatment Outcome | Coronary Angiography | Propensity Score | ST Elevation Myocardial Infarction - mortality | ST Elevation Myocardial Infarction - diagnostic imaging | Angina, Unstable - therapy | Acute Coronary Syndrome - therapy | Aged | Coronary Thrombosis - etiology | Non-ST Elevated Myocardial Infarction - mortality | Percutaneous Coronary Intervention - adverse effects | Angina, Unstable - diagnostic imaging | Transluminal angioplasty | Analysis | Cardiac patients | Tomography | Coronary heart disease | Thrombosis | Blood clot | Myocardial infarction | Intervention | Surgical implants | Statistical analysis | Medical imaging | Heart attacks | Angiography | Disorders | Patients | Incidence | Matching | Optical Coherence Tomography | Implants | Infarction | Acute coronary syndromes | Thromboembolism | Significance | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
2017, Volume 18, Issue 1
Book
International Journal of Cardiology, ISSN 0167-5273, 01/2020, Volume 299, pp. 49 - 55
Coronary Aneurysms are a focal dilatation of an artery segment >1.5-fold the normal size of adjacent segments. Although some series have suggested a prevalence...
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 116, Issue 2, pp. 325 - 331
Midterm outcomes for patients presenting with heart failure and functional mitral regurgitation (MR) treated with Mitraclip remain unclear. Pubmed, Medline,...
Cardiovascular | SURGERY | MODERATE | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | REDUCTION | HEART-FAILURE | TO-EDGE REPAIR | EXPERIENCE | OUTCOMES | VALVE REPAIR | ATRIAL-FIBRILLATION | Ventricular Function - physiology | Mitral Valve Insufficiency - surgery | Heart Valve Prosthesis | Humans | Ventricular Remodeling - physiology | Prosthesis Design | Mitral Valve Insufficiency - physiopathology | Heart failure | Heart | Complications and side effects | Care and treatment | Analysis | Atrial fibrillation | Cardiac patients | Mitral valve insufficiency | Studies | Confidence intervals | Hypothesis testing | Heart attacks | Deaths | Regression analysis | Cardiology | Meta-analysis
Cardiovascular | SURGERY | MODERATE | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | REDUCTION | HEART-FAILURE | TO-EDGE REPAIR | EXPERIENCE | OUTCOMES | VALVE REPAIR | ATRIAL-FIBRILLATION | Ventricular Function - physiology | Mitral Valve Insufficiency - surgery | Heart Valve Prosthesis | Humans | Ventricular Remodeling - physiology | Prosthesis Design | Mitral Valve Insufficiency - physiopathology | Heart failure | Heart | Complications and side effects | Care and treatment | Analysis | Atrial fibrillation | Cardiac patients | Mitral valve insufficiency | Studies | Confidence intervals | Hypothesis testing | Heart attacks | Deaths | Regression analysis | Cardiology | Meta-analysis
Journal Article
Annales. Histoire, Sciences Sociales, ISSN 0395-2649, 09/2014, Volume 69, Issue 3, pp. 801 - 804
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2010, Volume 28, Issue 34, pp. 5101 - 5109
Purpose The combination of bortezomib-melphalan-prednisone (VMP) is a new standard of care for newly diagnosed multiple myeloma. This phase III study examined...
SURVIVAL | ONCOLOGY-GROUP | THERAPY | ONCOLOGY | APEX TRIAL | LENALIDOMIDE PLUS DEXAMETHASONE | PERIPHERAL NEUROPATHY | INDUCTION | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Thalidomide - adverse effects | Prednisone - administration & dosage | Bortezomib | Prednisone - adverse effects | Multiple Myeloma - mortality | Humans | Pyrazines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Boronic Acids - adverse effects | Treatment Outcome | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Multiple Myeloma - drug therapy | Melphalan - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Boronic Acids - administration & dosage
SURVIVAL | ONCOLOGY-GROUP | THERAPY | ONCOLOGY | APEX TRIAL | LENALIDOMIDE PLUS DEXAMETHASONE | PERIPHERAL NEUROPATHY | INDUCTION | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Thalidomide - adverse effects | Prednisone - administration & dosage | Bortezomib | Prednisone - adverse effects | Multiple Myeloma - mortality | Humans | Pyrazines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Boronic Acids - adverse effects | Treatment Outcome | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Multiple Myeloma - drug therapy | Melphalan - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Boronic Acids - administration & dosage
Journal Article
American Journal of Hematology, ISSN 0361-8609, 12/2014, Volume 89, Issue 12, pp. 1085 - 1091
A subanalysis of the GIMEMA‐MMY‐3006 trial was performed to characterize treatment‐emergent peripheral neuropathy (PN) in patients randomized to...
DEXAMETHASONE | CYCLOPHOSPHAMIDE | CONSOLIDATION THERAPY | REVERSIBILITY | POLYMERIZATION | PREDNISONE PLUS THALIDOMIDE | STEM-CELL TRANSPLANTATION | HEMATOLOGY | ELDERLY-PATIENTS | MELPHALAN | INDUCTION TREATMENT | Peripheral Nervous System Diseases - chemically induced | Multiple Myeloma - mortality | Humans | Middle Aged | Pyrazines - administration & dosage | Syndecan-1 - genetics | Gene Expression Regulation, Neoplastic | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Male | Transplantation, Autologous | Plasma Cells - pathology | Neurogenesis - genetics | Multiple Myeloma - drug therapy | Neoplasm Grading | Bone Marrow Transplantation | Adult | Female | Plasma Cells - metabolism | Peripheral Nervous System Diseases - pathology | Boronic Acids - administration & dosage | Peripheral Nervous System Diseases - genetics | Actin Cytoskeleton - genetics | Thalidomide - adverse effects | Peripheral Nervous System Diseases - mortality | Actin Cytoskeleton - metabolism | Bortezomib | Dexamethasone - administration & dosage | Syndecan-1 - metabolism | Antineoplastic Combined Chemotherapy Protocols | Axons - metabolism | Thalidomide - administration & dosage | Multiple Myeloma - pathology | Axons - pathology | Adolescent | Pyrazines - adverse effects | Survival Analysis | Aged | Drug Monitoring | Multiple Myeloma - genetics
DEXAMETHASONE | CYCLOPHOSPHAMIDE | CONSOLIDATION THERAPY | REVERSIBILITY | POLYMERIZATION | PREDNISONE PLUS THALIDOMIDE | STEM-CELL TRANSPLANTATION | HEMATOLOGY | ELDERLY-PATIENTS | MELPHALAN | INDUCTION TREATMENT | Peripheral Nervous System Diseases - chemically induced | Multiple Myeloma - mortality | Humans | Middle Aged | Pyrazines - administration & dosage | Syndecan-1 - genetics | Gene Expression Regulation, Neoplastic | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Male | Transplantation, Autologous | Plasma Cells - pathology | Neurogenesis - genetics | Multiple Myeloma - drug therapy | Neoplasm Grading | Bone Marrow Transplantation | Adult | Female | Plasma Cells - metabolism | Peripheral Nervous System Diseases - pathology | Boronic Acids - administration & dosage | Peripheral Nervous System Diseases - genetics | Actin Cytoskeleton - genetics | Thalidomide - adverse effects | Peripheral Nervous System Diseases - mortality | Actin Cytoskeleton - metabolism | Bortezomib | Dexamethasone - administration & dosage | Syndecan-1 - metabolism | Antineoplastic Combined Chemotherapy Protocols | Axons - metabolism | Thalidomide - administration & dosage | Multiple Myeloma - pathology | Axons - pathology | Adolescent | Pyrazines - adverse effects | Survival Analysis | Aged | Drug Monitoring | Multiple Myeloma - genetics
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 1146 - 1146
The primary endpoint was the incidence of major adverse cardiac events (MACE), defined as the combination of all-cause mortality, myocardial infarction and...
Cardiovascular | Internal Medicine | Stents | Heart attacks
Cardiovascular | Internal Medicine | Stents | Heart attacks
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 02/2019, Volume 93, Issue 2, pp. 208 - 215
Objectives To compare the effectiveness and safety of self‐expandable, sirolimus‐eluting Stentys stents (SES) and second‐generation drug‐eluting stents...
percutaneous coronary intervention | second‐generation drug‐eluting stent | self‐expandable stent | unprotected left main | second-generation drug-eluting stent | self-expandable stent | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | MANAGEMENT | PERFORMANCE | RESTENOSIS | END-POINTS | INTERVENTION | CORONARY-ARTERY-DISEASE | ELEVATION MYOCARDIAL-INFARCTION | Transluminal angioplasty | Comparative analysis | Stent (Surgery) | Matching | Myocardial infarction | Surgical implants | Sirolimus | Implants | Bifurcations | Infarction | Angina | Thromboembolism | Thrombosis | Patients | Stents
percutaneous coronary intervention | second‐generation drug‐eluting stent | self‐expandable stent | unprotected left main | second-generation drug-eluting stent | self-expandable stent | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | MANAGEMENT | PERFORMANCE | RESTENOSIS | END-POINTS | INTERVENTION | CORONARY-ARTERY-DISEASE | ELEVATION MYOCARDIAL-INFARCTION | Transluminal angioplasty | Comparative analysis | Stent (Surgery) | Matching | Myocardial infarction | Surgical implants | Sirolimus | Implants | Bifurcations | Infarction | Angina | Thromboembolism | Thrombosis | Patients | Stents
Journal Article